Skip to main content
Top
Published in: Diabetologia 2/2009

01-02-2009 | Article

Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice

Authors: K. R. Coenen, M. L. Gruen, R. S. Lee-Young, M. J. Puglisi, D. H. Wasserman, A. H. Hasty

Published in: Diabetologia | Issue 2/2009

Login to get access

Abstract

Aims/hypothesis

Toll-like receptor 4 (TLR4) is a receptor for saturated fatty acids (SFAs), global deficiency of which has been shown to protect against inflammation, insulin resistance and atherosclerotic lesion formation. Because macrophages express Tlr4 and are important in insulin resistance and atherosclerotic lesion formation due to their infiltration of white adipose tissue (WAT) and the artery wall, respectively, we hypothesised that deficiency of macrophage TLR4 could protect against these disorders.

Methods

Bone marrow transplantation of agouti, LDL-receptor deficient (Ay/a; Ldlr −/−) mice with marrow from either C57BL/6 or Tlr4 −/− mice was performed. Recipient mice with Tlr4 +/+ marrow (MθTLR4+/+) or with Tlr4 −/− marrow (MθTLR4−/−) were then placed on one of four diets: (1) low fat; (2) high fat; (3) high fat rich in SFAs (HFSFA); and (4) HFSFA supplemented with fish oil.

Results

There were no differences in body composition or plasma lipids between MθTLR4+/+ and MθTLR4−/− mice on any of the diets. However, we observed a decrease in some macrophage and inflammatory markers in WAT of female low fat-fed MθTLR4−/− mice compared with MθTLR4+/+ mice. MθTLR4−/− mice fed low-fat diet also displayed decreased atherosclerotic lesion area. There were no differences in macrophage accrual in WAT or atherosclerosis between MθTLR4+/+ and MθTLR4−/− mice fed any of the high-fat diets. Finally, no difference was seen in insulin sensitivity between MθTLR4+/+ and MθTLR4−/− mice fed the HFSFA diet.

Conclusions/interpretation

These data suggest that under certain dietary conditions, macrophage expression of Tlr4 can be an important mediator of macrophage accumulation in WAT and the artery wall.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wang Y, Beydoun MA (2007) The obesity epidemic in the United States–gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28PubMedCrossRef Wang Y, Beydoun MA (2007) The obesity epidemic in the United States–gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28PubMedCrossRef
2.
go back to reference Reilly MP, Rader DJ (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108:1546–1551PubMedCrossRef Reilly MP, Rader DJ (2003) The metabolic syndrome: more than the sum of its parts? Circulation 108:1546–1551PubMedCrossRef
3.
go back to reference Moller DE, Kaufman KD (2005) Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 56:45–62PubMedCrossRef Moller DE, Kaufman KD (2005) Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 56:45–62PubMedCrossRef
4.
go back to reference Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMedCrossRef Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMedCrossRef
5.
go back to reference Adams KF, Schatzkin A, Harris TB et al (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778PubMedCrossRef Adams KF, Schatzkin A, Harris TB et al (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778PubMedCrossRef
6.
go back to reference Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. Jama 288:1723–1727PubMedCrossRef Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. Jama 288:1723–1727PubMedCrossRef
7.
go back to reference Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612PubMedCrossRef Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612PubMedCrossRef
8.
go back to reference Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821–1830PubMed Xu H, Barnes GT, Yang Q et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821–1830PubMed
9.
go back to reference Di Gregorio GB, Yao-Borengasser A, Rasouli N et al (2005) Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54:2305–2313PubMedCrossRef Di Gregorio GB, Yao-Borengasser A, Rasouli N et al (2005) Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54:2305–2313PubMedCrossRef
10.
go back to reference Kanda H, Tateya S, Tamori Y et al (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116:1494–1505PubMedCrossRef Kanda H, Tateya S, Tamori Y et al (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116:1494–1505PubMedCrossRef
11.
go back to reference Weisberg SP, Hunter D, Huber R et al (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116:115–124PubMedCrossRef Weisberg SP, Hunter D, Huber R et al (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116:115–124PubMedCrossRef
14.
go back to reference Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808PubMed Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808PubMed
15.
go back to reference Munford RS, Hall CL (1986) Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234:203–205PubMedCrossRef Munford RS, Hall CL (1986) Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234:203–205PubMedCrossRef
16.
go back to reference Hwang D (2001) Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways. Faseb J 15:2556–2564PubMedCrossRef Hwang D (2001) Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways. Faseb J 15:2556–2564PubMedCrossRef
17.
go back to reference Lee JY, Ye J, Gao Z et al (2003) Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 278:37041–37051PubMedCrossRef Lee JY, Ye J, Gao Z et al (2003) Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 278:37041–37051PubMedCrossRef
18.
go back to reference Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015–3025PubMedCrossRef Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015–3025PubMedCrossRef
19.
go back to reference Suganami T, Tanimoto-Koyama K, Nishida J et al (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27:84–91PubMedCrossRef Suganami T, Tanimoto-Koyama K, Nishida J et al (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27:84–91PubMedCrossRef
20.
go back to reference Lee JY, Sohn KH, Rhee SH, Hwang D (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276:16683–16689PubMedCrossRef Lee JY, Sohn KH, Rhee SH, Hwang D (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276:16683–16689PubMedCrossRef
21.
go back to reference Lee JY, Plakidas A, Lee WH et al (2003) Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 44:479–486PubMedCrossRef Lee JY, Plakidas A, Lee WH et al (2003) Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 44:479–486PubMedCrossRef
22.
go back to reference Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH (2005) Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol 174:5390–5397PubMed Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH (2005) Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol 174:5390–5397PubMed
23.
go back to reference Tsukumo DM, Carvalho-Filho MA, Carvalheira JB et al (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56:1986–1998PubMedCrossRef Tsukumo DM, Carvalho-Filho MA, Carvalheira JB et al (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56:1986–1998PubMedCrossRef
24.
go back to reference Poggi M, Bastelica D, Gual P et al (2007) C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50:1267–1276PubMedCrossRef Poggi M, Bastelica D, Gual P et al (2007) C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50:1267–1276PubMedCrossRef
25.
go back to reference Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y (2007) Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun 354:45–49PubMedCrossRef Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y (2007) Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun 354:45–49PubMedCrossRef
26.
go back to reference Coenen KR, Gruen ML, Chait A, Hasty AH (2007) Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue. Diabetes 56:564–573PubMedCrossRef Coenen KR, Gruen ML, Chait A, Hasty AH (2007) Diet-induced increases in adiposity, but not plasma lipids, promote macrophage infiltration into white adipose tissue. Diabetes 56:564–573PubMedCrossRef
27.
go back to reference Coenen KR, Hasty AH (2007) Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis in high fat diet-fed agouti LDLR deficient mice. Am J Physiol Endocrinol Metab 293:E492–E499PubMedCrossRef Coenen KR, Hasty AH (2007) Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis in high fat diet-fed agouti LDLR deficient mice. Am J Physiol Endocrinol Metab 293:E492–E499PubMedCrossRef
28.
go back to reference Ayala JE, Bracy DP, McGuinness OP, Wasserman DH (2006) Considerations in the design of hyperinsulinemic-euglycaemic clamps in the conscious mouse. Diabetes 55:390–397PubMedCrossRef Ayala JE, Bracy DP, McGuinness OP, Wasserman DH (2006) Considerations in the design of hyperinsulinemic-euglycaemic clamps in the conscious mouse. Diabetes 55:390–397PubMedCrossRef
29.
go back to reference Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408PubMedCrossRef Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408PubMedCrossRef
30.
go back to reference Saraswathi V, Hasty AH (2006) The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages. J Lipid Res 47:1406–1415PubMedCrossRef Saraswathi V, Hasty AH (2006) The role of lipolysis in mediating the proinflammatory effects of very low density lipoproteins in mouse peritoneal macrophages. J Lipid Res 47:1406–1415PubMedCrossRef
31.
go back to reference Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME (2008) Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 16:1248–1255CrossRef Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME (2008) Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 16:1248–1255CrossRef
32.
go back to reference Subramanian S, Han CY, Chiba T et al (2008) Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28:685–691PubMedCrossRef Subramanian S, Han CY, Chiba T et al (2008) Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28:685–691PubMedCrossRef
33.
go back to reference Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298–1308PubMedCrossRef Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298–1308PubMedCrossRef
34.
go back to reference Lu D, Willard D, Patel IR et al (1994) Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371:799–802PubMedCrossRef Lu D, Willard D, Patel IR et al (1994) Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371:799–802PubMedCrossRef
35.
go back to reference Saraswathi V, Gao L, Morrow JD, Chait A, Niswender KD, Hasty AH (2007) Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. J Nutr 137:1776–1782PubMed Saraswathi V, Gao L, Morrow JD, Chait A, Niswender KD, Hasty AH (2007) Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. J Nutr 137:1776–1782PubMed
36.
go back to reference Michelsen KS, Arditi M (2006) Toll-like receptor signaling and atherosclerosis. Curr Opin Hematol 13:163–168PubMedCrossRef Michelsen KS, Arditi M (2006) Toll-like receptor signaling and atherosclerosis. Curr Opin Hematol 13:163–168PubMedCrossRef
37.
go back to reference Pasterkamp G, van Keulen JK, de Kleijn DP (2004) Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 34:328–334PubMedCrossRef Pasterkamp G, van Keulen JK, de Kleijn DP (2004) Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 34:328–334PubMedCrossRef
38.
go back to reference Michelsen KS, Wong MH, Shah PK et al (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A 101:10679–10684PubMedCrossRef Michelsen KS, Wong MH, Shah PK et al (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A 101:10679–10684PubMedCrossRef
39.
go back to reference Michelsen KS, Doherty TM, Shah PK, Arditi M (2004) TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 173:5901–5907PubMed Michelsen KS, Doherty TM, Shah PK, Arditi M (2004) TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 173:5901–5907PubMed
40.
go back to reference Arbour NC, Lorenz E, Schutte BC et al (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187–191PubMedCrossRef Arbour NC, Lorenz E, Schutte BC et al (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187–191PubMedCrossRef
41.
go back to reference Kiechl S, Lorenz E, Reindl M et al (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185–192PubMedCrossRef Kiechl S, Lorenz E, Reindl M et al (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185–192PubMedCrossRef
42.
go back to reference Ameziane N, Beillat T, Verpillat P et al (2003) Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23:e61–e64PubMedCrossRef Ameziane N, Beillat T, Verpillat P et al (2003) Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23:e61–e64PubMedCrossRef
43.
go back to reference Hartvigsen K, Binder CJ, Hansen LF et al (2007) A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler Thromb Vasc Biol 27:878–885PubMedCrossRef Hartvigsen K, Binder CJ, Hansen LF et al (2007) A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler Thromb Vasc Biol 27:878–885PubMedCrossRef
Metadata
Title
Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice
Authors
K. R. Coenen
M. L. Gruen
R. S. Lee-Young
M. J. Puglisi
D. H. Wasserman
A. H. Hasty
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1221-7

Other articles of this Issue 2/2009

Diabetologia 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.